Condensed Statement of Cash Flows (Unaudited)	5 Months Ended
	Jun. 30, 2020 USD ($)
OPERATING ACTIVITIES
Net loss	$ (157,396)
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:
Interest earned on cash and marketable securities held in Trust Account	(7,715)
Interest receivable on cash and marketable securities held in Trust Account	(13,262)
Change in operating assets and liabilities:
Prepaid expenses	(136,648)
Other non-current assets	(101,834)
Accounts payable	6,918
Payable to related parties	5,343
Accrued liabilities	43,523
Other current liabilities	6,259
Net cash and cash equivalents used in operating activities	(354,812)
INVESTING ACTIVITIES
Investment of cash in Trust Account	(202,000,000)
Net cash and cash equivalents used in investing activities	(202,000,000)
FINANCING ACTIVITIES
Proceeds from sale of common stock to Founder	25,000
Proceeds from sale of common stock in initial public offering, net of underwriting discounts paid	196,000,000
Borrowing from a related party	100,000
Repayment of borrowing from a related party	(100,000)
Payment of deferred offering costs	(647,907)
Net cash and cash equivalents provided by financing activities	204,311,883
Net change in cash and cash equivalents during period	1,957,071
Cash and cash equivalents, end of period	1,957,071
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES
Offering costs included in accrued liabilities	100,000
Change in value of common stock subject to possible redemption	3,802,386
Founders
FINANCING ACTIVITIES
Proceeds from sale of common stock to private placement	6,500,000
Underwriters
FINANCING ACTIVITIES
Proceeds from sale of common stock to private placement	$ 2,434,790